SCHEMBL6173467

SCHEMBL6173467

CC(C)(C)OC(=O)N1CCc2ccc(N(CC(=O)Nc3ccc(-c4csc(N)n4)cc3)C(=O)c3ccc(F)cc3)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.41
▸ MAPT P10636 6/20 0.41
▸ NPC1 O15118 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.39
▸ TP53 P04637 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ KMT2A Q03164 4/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ GAA P10253 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173268 0.82 RAB9A (0.43) RAB9AMAPTNPC1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL6173338 0.80 RAB9A (0.50) RAB9AMAPTNPC1SMN1; SMN2ALDH1A1
SCHEMBL6171738 0.79 KMT2A (0.41) RAB9AMAPTNPC1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL6174507 0.78 KMT2A (0.40) RAB9AMAPTNPC1SMN1; SMN2ALDH1A1
SCHEMBL6173253 0.78 RAB9A (0.40) RAB9AMAPTNPC1SMN1; SMN2ALDH1A1
SCHEMBL27601474 0.78 KMT2A (0.41) RAB9AMAPTNPC1SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL6173065 0.78 NAMPT (0.39) RAB9AMAPTNPC1ALDH1A1KMT2A
SCHEMBL6173828 0.78 MEN1 (0.44) MAPTALDH1A1KMT2AMEN1HSD17B10
Hydrochloric Acid SCHEMBL6172863 0.77 KMT2A (0.39) RAB9AMAPTNPC1SMN1; SMN2ALDH1A1
SCHEMBL27583802 0.77 KMT2A (0.48) RAB9AMAPTNPC1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949543-B2 Amide derivative YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2005-09-27 — — US disclosed
EP-1340750-B1 AMIDE DERIVATIVES YAMANOUCHI PHARMA CO LTD (JP) 2005-08-17 — — EP disclosed
US-20040034232-A1 Amide derivative ASTELLAS PHARMA INC. (JP) 2004-02-19 — — US disclosed
EP-1340750-A1 AMIDE DERIVATIVES YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2003-09-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034232-A1 Amide derivative HDAC2, ZC3HAV1, HDAC4 RAB9A 1475/4885MAPT 1746/4885NPC1 3690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback